These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 38795070)

  • 1. Combining Mefloquine with an Mcl-1 Inhibitor as a Novel Therapeutic Strategy for the Treatment of Nasopharyngeal Carcinoma.
    Dong J; Zhang J; Xiang G; Yang L
    Nutr Cancer; 2024; 76(8):736-744. PubMed ID: 38795070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Small molecule inhibitor TW-37 is tolerable and synergistic with chemotherapy in nasopharyngeal carcinoma.
    Lu Y; Huang H; Yang H; Chen D; Wu S; Jiang Z; Wang R
    Cell Cycle; 2017 Jul; 16(14):1376-1383. PubMed ID: 28696828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ABT-199-mediated inhibition of Bcl-2 as a potential therapeutic strategy for nasopharyngeal carcinoma.
    Wang Y; Wang Y; Fan X; Song J; Wu H; Han J; Lu L; Weng X; Nie G
    Biochem Biophys Res Commun; 2018 Sep; 503(3):1214-1220. PubMed ID: 30017199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gemcitabine and APG-1252, a novel small molecule inhibitor of BCL-2/BCL-XL, display a synergistic antitumor effect in nasopharyngeal carcinoma through the JAK-2/STAT3/MCL-1 signaling pathway.
    Luo F; Lu FT; Qiu MZ; Zhou T; Ma WJ; Luo M; Zeng KM; Luo QY; Pan WT; Zhang L; Xia ZF; Zhang ZH; Cao JX; Zhao HY; Zhang L; Yang DJ
    Cell Death Dis; 2021 Aug; 12(8):772. PubMed ID: 34354046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regorafenib inhibits growth, survival and angiogenesis in nasopharyngeal carcinoma and is synergistic with Mcl-1 inhibitor.
    Li J; Hua Q
    J Pharm Pharmacol; 2023 Sep; 75(9):1177-1185. PubMed ID: 37133348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preclinical evaluation of the dual mTORC1/2 inhibitor sapanisertib in combination with cisplatin in nasopharyngeal carcinoma.
    Zhang J; Jiang Y; Yu Y; Li J
    Eur J Pharmacol; 2022 Jan; 915():174688. PubMed ID: 34883074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual phosphoinositide 3-kinase/mammalian target of rapamycin inhibitor NVP-BEZ235 has a therapeutic potential and sensitizes cisplatin in nasopharyngeal carcinoma.
    Yang F; Qian XJ; Qin W; Deng R; Wu XQ; Qin J; Feng GK; Zhu XF
    PLoS One; 2013; 8(3):e59879. PubMed ID: 23533654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Jervine exhibits anticancer effects on nasopharyngeal carcinoma through promoting autophagic apoptosis via the blockage of Hedgehog signaling.
    Chen J; Wen B; Wang Y; Wu S; Zhang X; Gu Y; Wang Z; Wang J; Zhang W; Yong J
    Biomed Pharmacother; 2020 Dec; 132():110898. PubMed ID: 33113432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Naringin Induces ROS-Stimulated G
    Chen CH; Tien N; Yao CH; Chen SJ; Bau DT; Pandey S; Yang HL; Hseu YC; Chen SS; Lin ML
    Environ Toxicol; 2024 Nov; 39(11):5059-5073. PubMed ID: 39056589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting nasopharyngeal carcinoma by artesunate through inhibiting Akt/mTOR and inducing oxidative stress.
    Li Q; Ni W; Deng Z; Liu M; She L; Xie Q
    Fundam Clin Pharmacol; 2017 Jun; 31(3):301-310. PubMed ID: 28078787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pectolinarigenin Suppresses the Tumor Growth in Nasopharyngeal Carcinoma.
    Wang C; Cheng Y; Liu H; Xu Y; Peng H; Lang J; Liao J; Liu H; Liu H; Fan J
    Cell Physiol Biochem; 2016; 39(5):1795-1803. PubMed ID: 27744436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bortezomib and SAHA synergistically induce ROS-driven caspase-dependent apoptosis of nasopharyngeal carcinoma and block replication of Epstein-Barr virus.
    Hui KF; Lam BH; Ho DN; Tsao SW; Chiang AK
    Mol Cancer Ther; 2013 May; 12(5):747-58. PubMed ID: 23475956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. XIAP Limits Autophagic Degradation of Sox2 and Is A Therapeutic Target in Nasopharyngeal Carcinoma Stem Cells.
    Ji J; Yu Y; Li ZL; Chen MY; Deng R; Huang X; Wang GF; Zhang MX; Yang Q; Ravichandran S; Feng GK; Xu XL; Yang CL; Qiu MZ; Jiao L; Yang D; Zhu XF
    Theranostics; 2018; 8(6):1494-1510. PubMed ID: 29556337
    [No Abstract]   [Full Text] [Related]  

  • 14. Isogarcinol inhibits nasopharyngeal carcinoma growth through mitochondria-mediated autophagic cell death.
    Li J; Shen X; Sun C; Hou Y; Hu Y; Ma S; Huang L; Ma L; Zhang Y; Dai X
    Phytomedicine; 2024 Jul; 130():155745. PubMed ID: 38833788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitory effects of 3-bromopyruvate in human nasopharyngeal carcinoma cells.
    Zou X; Zhang M; Sun Y; Zhao S; Wei Y; Zhang X; Jiang C; Liu H
    Oncol Rep; 2015 Oct; 34(4):1895-904. PubMed ID: 26239511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dichloroacetate enhances the anti-tumor effect of sorafenib via modulating the ROS-JNK-Mcl-1 pathway in liver cancer cells.
    Sun L; Jiang Y; Yan X; Dai X; Huang C; Chen L; Li T; Zhang Y; Xiao H; Yang M; Xiang L; Zhang Y; Chen S; Li S; Chen A; He F; Lian J
    Exp Cell Res; 2021 Sep; 406(1):112755. PubMed ID: 34332981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preclinical evaluation of ribociclib and its synergistic effect in combination with alpelisib in non-keratinizing nasopharyngeal carcinoma.
    Wong CH; Ma BBY; Hui CWC; Lo KW; Hui EP; Chan ATC
    Sci Rep; 2018 May; 8(1):8010. PubMed ID: 29789630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of Mcl-1 with the pan-Bcl-2 family inhibitor (-)BI97D6 overcomes ABT-737 resistance in acute myeloid leukemia.
    Pan R; Ruvolo VR; Wei J; Konopleva M; Reed JC; Pellecchia M; Andreeff M; Ruvolo PP
    Blood; 2015 Jul; 126(3):363-72. PubMed ID: 26045609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Casein kinase 1α-dependent inhibition of Wnt/β-catenin selectively targets nasopharyngeal carcinoma and increases chemosensitivity.
    Li J; Jiang Y; Wang P; Ke S; Yang L; Shen Y
    Anticancer Drugs; 2019 Aug; 30(7):e0747. PubMed ID: 31305293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic effect of TMZ-POH on human nasopharyngeal carcinoma depends on reactive oxygen species accumulation.
    Xie L; Song X; Guo W; Wang X; Wei L; Li Y; Lv L; Wang W; Chen TC; Song X
    Oncotarget; 2016 Jan; 7(2):1651-62. PubMed ID: 26625208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.